Read Lenskart Solutions IPO Review and Analysis on The Economic Times. Find out Lenskart Solutions IPO Issue Price, Subscription Dates and Status, Lenskart Solutions IPO Listing Date and more.

This special report focuses on Devyani Rana, the Bharatiya Janata Party's (BJP) candidate for the Nagrota Assembly by-poll and daughter of the late political leader, Devinder Singh Rana. In an ...

SRINAGAR: The Bharatiya Janata Party (BJP) has announced its list of candidates for the upcoming Assembly Bye-Elections 2025, scheduled to take place across multiple states, including Jammu and ...

Srinagar: The Bharatiya Janata Party on Wednesday named Devyani Rana and Aga Syed Mohsin as its candidates for by-polls in Jammu and Kashmir. As per news agency—Kashmir News Observer(KNO), the central ...

Tata Capital Ltd. has had a muted listing today, after raising as much as $1.75 billion in India’s biggest IPO of 2025. On Monday (13 October 2025), the Tata Capital share price rose as much as 2.08% ...

Oct 13 (Reuters) - Indian asset manager Canara Robeco's (CANE.NS), opens new tab nearly $150 million initial public offering (IPO) was fully subscribed on Monday, the final day of its three-day ...

Fermi, a Texas company aiming to power data centers with natural-gas plants and nuclear reactors, is moving at the speed of AI.

Security services group Verisure Plc ’s shares rallied in its first day of trading, after the initial public offering raised about €3.2 billion ($3.72 billion) in the largest European debut in three ...

More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...

Databricks recently reached a valuation exceeding $100 billion following its latest funding round, joining the elite group of most-valuable private companies like SpaceX, ByteDance and OpenAI.

The IPO market is coming back to life in 2025, fueled by a favorable business climate under President Donald Trump’s second term and a burst in investor demand for new equity stories as risk sentiment ...

Peter Marks, M.D., Ph.D., the former head of the FDA’s Center for Biologics Evaluation and Research (CBER), has joined Eli Lilly as senior vice president of molecule discovery and head of infectious ...